The American embassy in Peru has warned Americans against taking traditional psychedelics like the ayahuasca brew while in Peru. They cautioned that this mixture contains DMT, which is a potent hallucinogen that’s illegal in the U.S. and several other countries.
The embassy officials added that consuming the brew or even kambo, a psychoactive substance extracted from certain frogs, can trigger adverse health effects while also elevating a person’s risk of being robbed, sexually assaulted, or being a victim of other crimes. The health alert issued by the embassy also revealed that the psychoactive substances are usually marketed to people traveling within Peru and they are said to be “spiritual cleansers” or “ceremonial drinks.”
The embassy cautioned that the groups or individuals offering these substances aren’t regulated by the government and they don’t adhere to any known safety or health practices or regulations.
The alert explains that ayahuasca has been known to cause several negative effects, such as vomiting, nausea, elevated heart rate or even death. It cites examples of Americans who were severely ill or even died last year after consuming these psychoactive substances. They say the probability of severe health complications increases because the hallucinogens are usually taken in remote locations that aren’t within easy reach of well-equipped medical facilities.
The embassy says a number of Americans have reported being robbed, sexually assaulted or injured while they were “tripping” on psychedelics at “retreats” or “healing centers.”
Americans have been going to countries in South America for long in a bid to access traditional psychedelics like ayahuasca brews. These substances have been used by traditional communities for religious and healing purposes for a number of centuries. Particularly, U.S. veterans have flocked to Peru to use these hallucinogens as a last-ditch effort to get relief from conditions like PTSD or other psychiatric issues arising from their war experiences.
The research community has also shown increasing interest in studying these substances. As a result, the DEA has been increasing its production quotas in order to avail more supplies of these substances to groups interested in conducting studies on them. It is hoped that the studies will increase our understanding of psychedelics and later yield approved treatments that can help those who aren’t responding to the existing treatments.
Entities like Compass Pathways PLC (NASDAQ: CMPS) are making progress in their efforts to develop psychedelic treatments that meet regulatory approval requirements. Hopefully, their efforts will yield results sooner rather than later.
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com
PsychedelicNewsWire is powered by IBN
